Gleevec and the possibility of birth defects
Dear OncoLink "Ask The Experts,"
My brother is taking Gleevec and his wife wanted a child. Now she is pregnant and my family is concerned that this chemotherapy can be a cause for fetal anomalies.
Selina M. Luger, MD, Director of the Leukemia Program and Assistant Professor of Medicine at the University of Pennsylvania, responds:
Gleevec has never been given to pregnant women and on the clinical trials that were performed all participants, men as well as women as well as their partners were required to use contraception. Gleevec (Imatinib mesylate) has caused significant birth defects in rats when given at the doses equivalent to those used in humans. As such, unfortunately there is a risk of birth defects and this should be discussed with the wife's obstetrician as well as the patient's physician.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2016 Trustees of The University of Pennsylvania